HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in children

AIDS

Volumn 15, Issue 9, 2001, Pages 1187-1188

  Kamya, Moses R ^a   Kigonya, Catherine N ^a   McFarland, Willi ^b  

^a MAKERERE UNIVERSITY   (Uganda)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; FOLLOW-UP STUDIES; HIV ANTIBODIES; HIV-1; HUMANS; INFANT; MALARIA, FALCIPARUM; MIDDLE AGED; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME; UGANDA;

EID: 0035876297     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200106150-00019     Document Type: Article

References (4)

1. Is there an interaction between human deficiency virus and Plasmodium falciparum?
2. Effect of HIV-1 and increasing immunosuppression on malaria parasitemia and clinical episodes in adults in rural Uganda: A cohort study
3. Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda
4. The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of falciparum malaria in Kampala, Uganda